Investigation of the Multimerization Region of the
http://www.100md.com
病菌学杂志 2005年第12期
School of Life Sciences, University of Sussex, Brighton BN1 9QG, United Kingdom
ABSTRACT
The K8 gene of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) shares many functional similarities with the BZLF1 gene of Epstein-Barr virus. The protein products of K8 and BZLF1, K-bZIP (RAP, K8) and Zta (BZLF1, ZEBRA, Z) have both been proposed to be members of the bZIP family of transcription factors, forming multimers via a coiled-coil motif termed a leucine zipper. Substantial evidence supporting this model for Zta is published. Here, we demonstrate that the proposed leucine zipper region of K-bZIP (amino acids 182 to 218) is required for multimer formation but that it does not fold as a coiled coil.
TEXT
Kaposi's sarcoma-associated herpesvirus (KSHV) (or human herpesvirus 8 [HHV8]) is implicated in the development of three potentially fatal human diseases (reviewed in references 6, 7, 11, 20, 30, 37, 38, and 45). It is a member of the human gammaherpesvirus family, and its genome displays sequence homology with the prototypical member of the family, Epstein-Barr virus (EBV) (34). The K8 gene of KSHV encodes K-bZIP (RAP, K8) which is involved in viral lytic replication (5, 25, 48). K-bZIP interacts with replication structures (4, 47) and with three individual cellular proteins, p53 (31), CBP (19), and C/EBP (51), and it regulates the expression of the cellular gene encoding p21CIP1 (51). Thus, K-bZIP is a candidate to mediate two important events: viral replication and cell cycle arrest (41).
K8 appears to be a homologue of the EBV gene BZLF1 (14, 26, 32). The protein encoded by BZLF1, Zta (BZLF1, ZEBRA, or Z), plays a key role in the EBV replicative cycle (reviewed in references 12, 29, 39, 41, and 43). Zta also shares with K-bZIP the ability to interact with its origin of lytic replication (35, 36), to promote cell cycle arrest (13), and to interact with the cellular proteins p53, CBP, and C/EBP (1, 28, 41, 50, 52, 53). Given the functional similarities between these two proteins, it is tempting to speculate that a similar molecular mechanism is exploited by each virus to achieve the same ends.
The overall homology between K-bZIP and Zta is low but rises to 30% similarity (18% identity) within the C-terminal half. This region contains the well-characterized bZIP domain of Zta, which directs the formation of homodimers through the leucine zipper motif and interacts with DNA through the adjacent basic region (15, 16, 29, 39, 41-43). Interestingly, both K-bZIP and Zta form homo-multimers involving the C-terminal half of the protein (14, 26), suggesting that multimerization could be mediated in a similar manner for both viral proteins. In this study, we question whether K-bZIP contains a functional bZIP domain.
Similarities between Zta and K-bZIP primary and secondary structures are illustrated in Fig. 1. Alignment of the carboxy-terminal halves of both Zta and K-bZIP using ClustalW (17, 46) reveals scattered homology throughout the putative basic and leucine zipper regions. Leucine zipper multimerization domains comprise two strands of -helix, which fold together through a hydrophobic face on each helix to form a coiled-coil structure (3, 8, 24, 44). Bioinformatics analyses using the program COILS (27) revealed that the proposed leucine zipper region of K-bZIP is predicted to fold as a coiled coil, as Zta does. This prompted us to question experimentally whether K-bZIP is able to undertake the two key functions of a bZIP protein, namely, (i) to interact with DNA or (ii) to form multimers using a coiled-coil folding motif.
In light of the scattered homology between the basic (DNA contact) region of Zta and K-bZIP, we questioned whether K-bZIP is able to interact with an AP1 site. Polyhistidine-tagged versions of both full-length proteins were generated in vitro using a reticulocyte lysate translation system and equal amounts of each protein were added to an in vitro DNA-binding assay with AP1 and a mutant version of that site (as described in reference 15). As expected, only His-Zta showed a clear interaction with the AP1 site (data not shown).
We sought to determine whether K-bZIP encodes a leucine zipper domain by undertaking domain swaps with the bZIP protein Zta. Functional swaps of the leucine zipper have been documented for this protein with leucine zippers of other members of the bZIP family (for an example, see reference 49). Using the alignment shown in Fig. 1, the first domain swap maintained the exact register of the alignment, ending Zta at amino acid Q198 and replacing the remainder of the coding sequence with amino acids A190 to the carboxyl terminus of K-bZIP (Fig. 2). His-Zta and His-K-bZIP proteins were generated in vitro, and their ability to interact with DNA was assessed using a DNA-binding assay. Surprisingly, this exchange did not result in a hybrid protein capable of interacting with AP1. The alignment of the basic and leucine zipper regions is important for the function of b-ZIP proteins (2, 23), so six further domain swaps were generated that contained between zero and four alanine residues between the basic and proposed zipper regions in order to align the proposed zipper in different conformations with respect to the basic region. However, none of the hybrids was able to interact with DNA, suggesting that a functional bZIP domain is not formed by any of the combinations tested. It is possible that this approach omitted a crucial configuration; however, the data shown lend no support to a model in which the putative zipper region of K-bZIP contains a functional leucine zipper.
In order to probe whether the predicted coiled coil within the putative bZIP region of K-bZIP is required for multimerization, a deletion mutant, lacking amino acids 182 to 218, was generated by site-directed mutagenesis. The ability of a polyhistidine-tagged version of this protein, His-K-ZIP, to form multimers with full-length K-bZIP (14) was assessed using an in vitro association assay with a glutathione S-transferase (GST)-tagged version of K-bZIP (Fig. 3). In conditions where no association between GST and His-K-bZIP or GST-K-bZIP and His-Zta was observed, His-K-bZIP showed a clear association with the full-length GST-K-bZIP. Furthermore, the deletion within His-K-ZIP prevented association with GST-K-bZIP, thus demonstrating a role for amino acids 182 to 218 in multimerization. We then explored the ability of the hybrid proteins to form multimers with full-length K-bZIP protein. His-K-bZIP showed a strong association with GST-K-bZIP, whereas His-Zta revealed negligible binding, setting the background level of the assay (2% of the binding of His-K-bZIP). All of the His-Z-K hybrids showed a degree of multimerization, with His-Z-K1 and His-K-6 reaching over 20% of the binding of His-K-bZIP and His-Z-K and with His-Z-K2 and His-Z-K3 clearly also forming multimers. This demonstrates that the region of K-bZIP between 190 and 237 contains a multimerization domain that can transfer its function onto another protein.
The proposed leucine zipper region of K-bZIP is predicted to have a high probability of folding as a coiled coil, according to the analysis shown in Fig. 1. We questioned whether this occurs by using two biophysical approaches. A synthetic peptide was generated that was equivalent to the region of Zta that we had previously shown to fold as a coiled coil in vitro (16). The propensity of the K-bZIP peptide to fold as an -helix was assessed first using circular dichroism (CD) spectroscopy. Using this spectroscopic technique, -helical peptides generate a CD spectrum with two characteristic minima, at 208 and 222 nm. The biophysical properties of the synthetic peptide were analyzed at two concentrations and two pH conditions, pH 7.0 and pH 3.7, where it displayed a greater solubility. All of the data sets generated similar results. A lack of concentration dependence is indicative of this peptide folding as a monomeric species in solution. Surprisingly, none of the data revealed -helical minima at 222 nm and 208 nm (Fig. 4), suggesting that the peptide did not fold in an -helical conformation. Indeed, a single trough was observed at 218 nm, which is the characteristic signal generated by peptides folded as ?-sheets (21, 22). Further analysis of the folding of the K-bZIP peptide was undertaken using attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) (Fig. 4). This analysis revealed a peak for amide I bonds at 1,637 ± 4 cm–1 (characteristic of ?-sheet structure). The second derivative of the spectrum of the amide I peaks revealed four components, which all correspond to either ?-sheet or ?-turn structure (10).
Given the functional homology and sequence homology between K-bZIP and Zta, it is tempting to speculate that they contain a common structural element that acts in a similar manner within each protein to achieve their common functions. The obvious candidate for this is the bZIP domain that has been so well characterized for Zta and widely proposed to exist in K-bZIP. Evidence in favor of a bZIP structure for K-bZIP is summarized below.
The initial publications describing the transcript encoding K-bZIP and the primary structure of the protein identified and highlighted the presence of a heptad repeat of leucine residues within the carboxy-terminal half of the protein and termed it a leucine zipper (14, 26, 40, 54). Furthermore, K-bZIP folds as a multimer and the carboxy-terminal half of the protein is required for multimerization (14) (26). Analysis of the primary structure reveals two regions containing clusters of basic amino acid residues, but these do not have direct homology with the motif found in the basic region of bZIP proteins. Indeed, we did not observe any significant interaction between K-bZIP and an AP1 site in in vitro DNA-binding assays. However, it has recently been shown that K-bZIP expressed in vivo associates with DNA, specifically the lytic origin of replication (4, 48, 50). However, whether this occurs by a direct or indirect association and whether it involves the proposed bZIP region remain to be firmly established.
Recently, AuCoin et al. elegantly demonstrated that K-bZIP is required for replication through the lytic origin of the KSHV genome (4) and, furthermore, that this function requires contributions from both the amino- and carboxy-terminal halves of K-bZIP. During their further investigation of the contribution from the carboxy-terminal half of the protein, they generated a series of mutations in the heptad of leucine residues within the proposed leucine zipper region by replacing between one and four leucines in each mutant. Interestingly, two of the resulting mutants retained the ability to replicate through the lytic origin of replication and two lost this function. This study clearly demonstrates that K-bZIP is required for replication through the KSHV lytic origin of replication and, furthermore, it shows a contribution from some of the leucine residues within the proposed zipper to that function. However, no experiments involving multimerization or other biophysical properties were undertaken, and this set of data could be used equally well to support or to detract from a bZIP model for the K-bZIP protein.
Regarding multimerization, we demonstrate that amino acids 190 to 237 of K-bZIP contain a transferable multimerization domain. Although additional contributions from amino acids out of this region cannot be excluded, these amino acids clearly contain sufficient inherent information to fold into a stable multimeric structure. K-bZIP therefore appears to conform to the bZIP model, in terms of the ability to multimerize using the proposed bZIP region; however, the similarity ends there. The proposed zipper region of K-bZIP is not able to confer DNA-binding ability onto the basic region of Zta, despite the ability of several of the hybrid proteins to fold as multimers.
Finally, our biophysical investigations not only fail to support the leucine zipper model but demonstrate that this region preferentially folds into a different secondary structure. The synthetic K-bZIP peptide corresponding to the proposed leucine zipper of K-bZIP appears to fold as a ?-sheet rather than as an -helix in two distinct in vitro assays; CD spectroscopy and FTIR-ATR (Fig. 4). It is worth noting that many sequences that were predicted to fold as -helices have been shown, using biophysical measurements, to actually fold as ?-sheets; these have been termed false zippers (18).
Although ?-sheets can form multimeric interfaces in vitro (9, 33), we observed no concentration dependence on the strength of the ?-sheet signal observed for the CD spectra, which suggests that the peptide contains insufficient information to fold as multimers. Therefore, despite the clear involvement of the region containing the ?-sheet to the multimerization of K-bZIP, it remains to be determined whether multimerization requires a ?-sheet interface or whether the ?-sheet stabilizes the formation of a different multimerization interface employing amino acids that lie outside residues 182 to 218.
The balance of evidence presented here suggests that the proposed bZIP region within K-bZIP is unlikely to function as a bZIP motif, unlike that of Zta. So, although Zta and K-bZIP hold many functions in common, we conclude that it is unlikely that they exploit similar molecular mechanisms to effect those functions.
ACKNOWLEDGMENTS
Henri Gruffat (Lyon) kindly provided a vector encoding K-bZIP, George Papadakis helped to generate the His-tagged version of K-bZIP, Matthew Hicks generated the His-tagged version of Zta, and Derek Woolfson (University of Sussex) advised on biophysical analyses.
This work is supported by grants from the Wellcome trust to A.S. and from the BBSRC (B17958) to Derek Woolfson. S.A.M. was supported by a studentship from the government of the United Arab Emirates.
REFERENCES
Adamson, A. L., and S. Kenney. 1999. The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J. Virol. 73:6551-6558.
Agre, P., P. F. Johnson, and S. L. McKnight. 1989. Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science 246:922-926.
Alber, T. 1992. Structure of the leucine zipper. Curr. Opin. Genet. Dev. 2:205-210.
AuCoin, D. P., K. S. Colletti, S. A. Cei, I. Papouskova, M. Tarrant, and G. S. Pari. 2004. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP). Virology 318:542-555.
AuCoin, D. P., K. S. Colletti, Y. Xu, S. A. Cei, and G. S. Pari. 2002. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication. J. Virol. 76:7890-7896.
Boshoff, C. 1998. Kaposi's sarcoma-associated herpesvirus: the second human gammaherpesvirus. Epstein-Barr Virus Rep. 5:3-9.
Boshoff, C., and R. A. Weiss. 1998. Kaposi's sarcoma associated herpesvirus. Adv. Cancer Res. 75:57-86.
Busch, S. J., and P. Sassone-Corsi. 1990. Dimers, leucine zippers and DNA-binding domains. Trends Genet. 6:36-40.
Cox, A., M. M. Arroyo, and K. H. Mayo. 2001. Folding of ?pep-4 ?-sheet sandwich dimers and tetramers is influenced by aliphatic hydrophobic residues at the intersubunit interface. Biochem. J. 357:739-747.
Dong, A., P. Huang, and W. S. Caughey. 1990. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 29:3303-3308.
Dourmishev, L. A., A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac. 2003. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol. Mol. Biol. Rev. 67:175-212.
Feederle, R., M. Kost, M. Baumann, A. Janz, E. Drouet, W. Hammerschmidt, and H. J. Delecluse. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19:3080-3089.
Flemington, E. K. 2001. Herpesvirus lytic replication and the cell cycle: arresting new developments. J. Virol. 75:4475-4481.
Gruffat, H., S. Portes-Sentis, A. Sergeant, and E. Manet. 1999. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1. J. Gen. Virol. 80:557-561.
Hicks, M. R., S. S. Al-Mehairi, and A. J. Sinclair. 2003. The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding. J. Virol. 77:8173-8177.
Hicks, M. R., S. Balesaria, C. Medina-Palazon, M. J. Pandya, D. N. Woolfson, and A. J. Sinclair. 2001. Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. J. Virol. 75:5381-5384.
Higgins, D. G. 1994. CLUSTAL V: multiple alignment of DNA and protein sequences. Methods Mol. Biol. 25:307-318.
Hirst, J. D., M. Vieth, J. Skolnick, and C. L. Brooks III. 1996. Predicting leucine zipper structures from sequence. Protein Eng. 9:657-662.
Hwang, S., Y. Gwack, H. Byun, C. Lim, and J. Choe. 2001. The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J. Virol. 75:9509-9516.
Jenner, R. G., and C. Boshoff. 2002. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim. Biophys. Acta 1602:1-22.
Kelly, S. M., and N. C. Price. 1997. The application of circular dichroism to studies of protein folding and unfolding. Biochim. Biophys. Acta 1338:161-185.
Kelly, S. M., and N. C. Price. 2000. The use of circular dichroism in the investigation of protein structure and function. Curr. Protein Pept. Sci. 1:349-384.
Kouzarides, T., G. Packham, A. Cook, and P. J. Farrell. 1991. The BZLF1 protein of EBV has a coiled coil dimerization domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene 6:195-204.
Kouzarides, T., and E. Ziff. 1989. Behind the Fos and Jun leucine zipper. Cancer Cells 1:71-76.
Lin, C. L., H. Li, Y. Wang, F. X. Zhu, S. Kudchodkar, and Y. Yuan. 2003. Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin. J. Virol. 77:5578-5588.
Lin, S. F., D. R. Robinson, G. Miller, and H. J. Kung. 1999. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J. Virol. 73:1909-1917.
Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from protein sequences. Science 252:1162-1164.
Mauser, A., S. Saito, E. Appella, C. W. Anderson, W. T. Seaman, and S. Kenney. 2002. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 76:12503-12512.
Miller, G. 1989. The switch between EBV latency and replication. Yale J. Biol. Med. 62:205-213.
Moore, P., and Y. Chang. 1998. Identification of Kaposi's sarcoma-associated sequences of non-human origin. Epstein-Barr Virus Rep. 5:1-2.
Park, J., T. Seo, S. M. Hwang, D. Lee, Y. Gwack, and J. Choe. 2000. The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J. Virol. 74:11977-11982.
Portes-Sentis, S., E. Manet, G. Gourru, A. Sergeant, and H. Gruffat. 2001. Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein. J. Gen. Virol. 82:507-512.
Richardson, J. S., and D. C. Richardson. 2002. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. USA 99:2754-2759.
Russo, J. J., R. A. Bohenzky, M.-C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93:14862-14867.
Schepers, A., D. Pich, and W. Hammerschmidt. 1996. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220:367-376.
Schepers, A., D. Pich, and W. Hammerschmidt. 1993. A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J. 12:3921-3929.
Schultz, T. F. 1998. Kaposi's sarcoma-associated herpesvirus (HHV-8). J. Gen. Virol. 79:1573-1591.
Schultz, T. F. 1998. KSHV—the middle game. Epstein-Barr Virus Rep. 5:101-107.
Schwarzmann, F., M. Jager, N. Prang, and H. Wolf. 1998. The control of lytic replication of Epstein-Barr virus in B lymphocytes. Int. J. Mol. Med. 1:137-142.
Seaman, W. T., D. S. Ye, R. X. Wang, E. E. Hale, M. Weisse, and E. B. Quinlivan. 1999. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263:436-449.
Sinclair, A. J. 2003. bZIP proteins of human gamma herpesviruses. J. Gen. Virol. 84:1941-1949.
Sinclair, A. J., and P. J. Farrell. 1992. Epstein-Barr virus transcription factors. Cell Growth Differ. 3:557-563.
Speck, S. H., T. Chatila, and E. Flemington. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5:399-405.
Struhl, K. 1989. Helix-turn-helix, zinc-finger, and leucine-zipper motifs for eukaryotic transcriptional regulatory proteins. Trends Biochem. Sci. 14:137-140.
Talbot, S. J., and D. H. Crawford. 2004. Viruses and tumours—an update. Eur. J. Cancer 40:1998-2005.
Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
Wang, S. E., F. Y. Wu, H. Chen, M. Shamay, Q. Zheng, and G. S. Hayward. 2004. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 78:4248-4267.
Wang, Y., H. Li, M. Y. Chan, F. X. Zhu, D. M. Lukac, and Y. Yuan. 2004. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J. Virol. 78:8615-8629.
West, M. J., H. M. Webb, A. J. Sinclair, and D. N. Woolfson. 2004. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C. J. Virol. 78:9431-9445.
Wu, F. Y., H. Chen, S. E. Wang, C. M. apRhys, G. Liao, M. Fujimuro, C. J. Farrell, J. Huang, S. D. Hayward, and G. S. Hayward. 2003. CCAAT/enhancer-binding protein interacts with ZTA and mediates ZTA-induced p21CIP-1 accumulation and G1 cell cycle arrest during the Epstein-Barr virus lytic cycle. J. Virol. 77:1481-1500.
Wu, F. Y., Q. Q. Tang, H. Chen, C. ApRhys, C. Farrell, J. Chen, M. Fujimuro, M. D. Lane, and G. S. Hayward. 2002. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-. Proc. Natl. Acad. Sci. USA 99:10683-10688.
Zerby, D., C. J. Chen, E. Poon, D. Lee, R. Shiekhattar, and P. M. Lieberman. 1999. The amino-terminal C/H1 domain of CREB-binding protein mediates Zta transcriptional activation of latent Epstein-Barr virus. Mol. Cell. Biol. 19:1617-1626.
Zhang, Q., D. Gutsch, and S. Kenney. 1994. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14:1929-1938.
Zhu, F. X., T. Cusano, and Y. Yuan. 1999. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:5556-5567.(Salama Al Mehairi, Eleano)
ABSTRACT
The K8 gene of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) shares many functional similarities with the BZLF1 gene of Epstein-Barr virus. The protein products of K8 and BZLF1, K-bZIP (RAP, K8) and Zta (BZLF1, ZEBRA, Z) have both been proposed to be members of the bZIP family of transcription factors, forming multimers via a coiled-coil motif termed a leucine zipper. Substantial evidence supporting this model for Zta is published. Here, we demonstrate that the proposed leucine zipper region of K-bZIP (amino acids 182 to 218) is required for multimer formation but that it does not fold as a coiled coil.
TEXT
Kaposi's sarcoma-associated herpesvirus (KSHV) (or human herpesvirus 8 [HHV8]) is implicated in the development of three potentially fatal human diseases (reviewed in references 6, 7, 11, 20, 30, 37, 38, and 45). It is a member of the human gammaherpesvirus family, and its genome displays sequence homology with the prototypical member of the family, Epstein-Barr virus (EBV) (34). The K8 gene of KSHV encodes K-bZIP (RAP, K8) which is involved in viral lytic replication (5, 25, 48). K-bZIP interacts with replication structures (4, 47) and with three individual cellular proteins, p53 (31), CBP (19), and C/EBP (51), and it regulates the expression of the cellular gene encoding p21CIP1 (51). Thus, K-bZIP is a candidate to mediate two important events: viral replication and cell cycle arrest (41).
K8 appears to be a homologue of the EBV gene BZLF1 (14, 26, 32). The protein encoded by BZLF1, Zta (BZLF1, ZEBRA, or Z), plays a key role in the EBV replicative cycle (reviewed in references 12, 29, 39, 41, and 43). Zta also shares with K-bZIP the ability to interact with its origin of lytic replication (35, 36), to promote cell cycle arrest (13), and to interact with the cellular proteins p53, CBP, and C/EBP (1, 28, 41, 50, 52, 53). Given the functional similarities between these two proteins, it is tempting to speculate that a similar molecular mechanism is exploited by each virus to achieve the same ends.
The overall homology between K-bZIP and Zta is low but rises to 30% similarity (18% identity) within the C-terminal half. This region contains the well-characterized bZIP domain of Zta, which directs the formation of homodimers through the leucine zipper motif and interacts with DNA through the adjacent basic region (15, 16, 29, 39, 41-43). Interestingly, both K-bZIP and Zta form homo-multimers involving the C-terminal half of the protein (14, 26), suggesting that multimerization could be mediated in a similar manner for both viral proteins. In this study, we question whether K-bZIP contains a functional bZIP domain.
Similarities between Zta and K-bZIP primary and secondary structures are illustrated in Fig. 1. Alignment of the carboxy-terminal halves of both Zta and K-bZIP using ClustalW (17, 46) reveals scattered homology throughout the putative basic and leucine zipper regions. Leucine zipper multimerization domains comprise two strands of -helix, which fold together through a hydrophobic face on each helix to form a coiled-coil structure (3, 8, 24, 44). Bioinformatics analyses using the program COILS (27) revealed that the proposed leucine zipper region of K-bZIP is predicted to fold as a coiled coil, as Zta does. This prompted us to question experimentally whether K-bZIP is able to undertake the two key functions of a bZIP protein, namely, (i) to interact with DNA or (ii) to form multimers using a coiled-coil folding motif.
In light of the scattered homology between the basic (DNA contact) region of Zta and K-bZIP, we questioned whether K-bZIP is able to interact with an AP1 site. Polyhistidine-tagged versions of both full-length proteins were generated in vitro using a reticulocyte lysate translation system and equal amounts of each protein were added to an in vitro DNA-binding assay with AP1 and a mutant version of that site (as described in reference 15). As expected, only His-Zta showed a clear interaction with the AP1 site (data not shown).
We sought to determine whether K-bZIP encodes a leucine zipper domain by undertaking domain swaps with the bZIP protein Zta. Functional swaps of the leucine zipper have been documented for this protein with leucine zippers of other members of the bZIP family (for an example, see reference 49). Using the alignment shown in Fig. 1, the first domain swap maintained the exact register of the alignment, ending Zta at amino acid Q198 and replacing the remainder of the coding sequence with amino acids A190 to the carboxyl terminus of K-bZIP (Fig. 2). His-Zta and His-K-bZIP proteins were generated in vitro, and their ability to interact with DNA was assessed using a DNA-binding assay. Surprisingly, this exchange did not result in a hybrid protein capable of interacting with AP1. The alignment of the basic and leucine zipper regions is important for the function of b-ZIP proteins (2, 23), so six further domain swaps were generated that contained between zero and four alanine residues between the basic and proposed zipper regions in order to align the proposed zipper in different conformations with respect to the basic region. However, none of the hybrids was able to interact with DNA, suggesting that a functional bZIP domain is not formed by any of the combinations tested. It is possible that this approach omitted a crucial configuration; however, the data shown lend no support to a model in which the putative zipper region of K-bZIP contains a functional leucine zipper.
In order to probe whether the predicted coiled coil within the putative bZIP region of K-bZIP is required for multimerization, a deletion mutant, lacking amino acids 182 to 218, was generated by site-directed mutagenesis. The ability of a polyhistidine-tagged version of this protein, His-K-ZIP, to form multimers with full-length K-bZIP (14) was assessed using an in vitro association assay with a glutathione S-transferase (GST)-tagged version of K-bZIP (Fig. 3). In conditions where no association between GST and His-K-bZIP or GST-K-bZIP and His-Zta was observed, His-K-bZIP showed a clear association with the full-length GST-K-bZIP. Furthermore, the deletion within His-K-ZIP prevented association with GST-K-bZIP, thus demonstrating a role for amino acids 182 to 218 in multimerization. We then explored the ability of the hybrid proteins to form multimers with full-length K-bZIP protein. His-K-bZIP showed a strong association with GST-K-bZIP, whereas His-Zta revealed negligible binding, setting the background level of the assay (2% of the binding of His-K-bZIP). All of the His-Z-K hybrids showed a degree of multimerization, with His-Z-K1 and His-K-6 reaching over 20% of the binding of His-K-bZIP and His-Z-K and with His-Z-K2 and His-Z-K3 clearly also forming multimers. This demonstrates that the region of K-bZIP between 190 and 237 contains a multimerization domain that can transfer its function onto another protein.
The proposed leucine zipper region of K-bZIP is predicted to have a high probability of folding as a coiled coil, according to the analysis shown in Fig. 1. We questioned whether this occurs by using two biophysical approaches. A synthetic peptide was generated that was equivalent to the region of Zta that we had previously shown to fold as a coiled coil in vitro (16). The propensity of the K-bZIP peptide to fold as an -helix was assessed first using circular dichroism (CD) spectroscopy. Using this spectroscopic technique, -helical peptides generate a CD spectrum with two characteristic minima, at 208 and 222 nm. The biophysical properties of the synthetic peptide were analyzed at two concentrations and two pH conditions, pH 7.0 and pH 3.7, where it displayed a greater solubility. All of the data sets generated similar results. A lack of concentration dependence is indicative of this peptide folding as a monomeric species in solution. Surprisingly, none of the data revealed -helical minima at 222 nm and 208 nm (Fig. 4), suggesting that the peptide did not fold in an -helical conformation. Indeed, a single trough was observed at 218 nm, which is the characteristic signal generated by peptides folded as ?-sheets (21, 22). Further analysis of the folding of the K-bZIP peptide was undertaken using attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR) (Fig. 4). This analysis revealed a peak for amide I bonds at 1,637 ± 4 cm–1 (characteristic of ?-sheet structure). The second derivative of the spectrum of the amide I peaks revealed four components, which all correspond to either ?-sheet or ?-turn structure (10).
Given the functional homology and sequence homology between K-bZIP and Zta, it is tempting to speculate that they contain a common structural element that acts in a similar manner within each protein to achieve their common functions. The obvious candidate for this is the bZIP domain that has been so well characterized for Zta and widely proposed to exist in K-bZIP. Evidence in favor of a bZIP structure for K-bZIP is summarized below.
The initial publications describing the transcript encoding K-bZIP and the primary structure of the protein identified and highlighted the presence of a heptad repeat of leucine residues within the carboxy-terminal half of the protein and termed it a leucine zipper (14, 26, 40, 54). Furthermore, K-bZIP folds as a multimer and the carboxy-terminal half of the protein is required for multimerization (14) (26). Analysis of the primary structure reveals two regions containing clusters of basic amino acid residues, but these do not have direct homology with the motif found in the basic region of bZIP proteins. Indeed, we did not observe any significant interaction between K-bZIP and an AP1 site in in vitro DNA-binding assays. However, it has recently been shown that K-bZIP expressed in vivo associates with DNA, specifically the lytic origin of replication (4, 48, 50). However, whether this occurs by a direct or indirect association and whether it involves the proposed bZIP region remain to be firmly established.
Recently, AuCoin et al. elegantly demonstrated that K-bZIP is required for replication through the lytic origin of the KSHV genome (4) and, furthermore, that this function requires contributions from both the amino- and carboxy-terminal halves of K-bZIP. During their further investigation of the contribution from the carboxy-terminal half of the protein, they generated a series of mutations in the heptad of leucine residues within the proposed leucine zipper region by replacing between one and four leucines in each mutant. Interestingly, two of the resulting mutants retained the ability to replicate through the lytic origin of replication and two lost this function. This study clearly demonstrates that K-bZIP is required for replication through the KSHV lytic origin of replication and, furthermore, it shows a contribution from some of the leucine residues within the proposed zipper to that function. However, no experiments involving multimerization or other biophysical properties were undertaken, and this set of data could be used equally well to support or to detract from a bZIP model for the K-bZIP protein.
Regarding multimerization, we demonstrate that amino acids 190 to 237 of K-bZIP contain a transferable multimerization domain. Although additional contributions from amino acids out of this region cannot be excluded, these amino acids clearly contain sufficient inherent information to fold into a stable multimeric structure. K-bZIP therefore appears to conform to the bZIP model, in terms of the ability to multimerize using the proposed bZIP region; however, the similarity ends there. The proposed zipper region of K-bZIP is not able to confer DNA-binding ability onto the basic region of Zta, despite the ability of several of the hybrid proteins to fold as multimers.
Finally, our biophysical investigations not only fail to support the leucine zipper model but demonstrate that this region preferentially folds into a different secondary structure. The synthetic K-bZIP peptide corresponding to the proposed leucine zipper of K-bZIP appears to fold as a ?-sheet rather than as an -helix in two distinct in vitro assays; CD spectroscopy and FTIR-ATR (Fig. 4). It is worth noting that many sequences that were predicted to fold as -helices have been shown, using biophysical measurements, to actually fold as ?-sheets; these have been termed false zippers (18).
Although ?-sheets can form multimeric interfaces in vitro (9, 33), we observed no concentration dependence on the strength of the ?-sheet signal observed for the CD spectra, which suggests that the peptide contains insufficient information to fold as multimers. Therefore, despite the clear involvement of the region containing the ?-sheet to the multimerization of K-bZIP, it remains to be determined whether multimerization requires a ?-sheet interface or whether the ?-sheet stabilizes the formation of a different multimerization interface employing amino acids that lie outside residues 182 to 218.
The balance of evidence presented here suggests that the proposed bZIP region within K-bZIP is unlikely to function as a bZIP motif, unlike that of Zta. So, although Zta and K-bZIP hold many functions in common, we conclude that it is unlikely that they exploit similar molecular mechanisms to effect those functions.
ACKNOWLEDGMENTS
Henri Gruffat (Lyon) kindly provided a vector encoding K-bZIP, George Papadakis helped to generate the His-tagged version of K-bZIP, Matthew Hicks generated the His-tagged version of Zta, and Derek Woolfson (University of Sussex) advised on biophysical analyses.
This work is supported by grants from the Wellcome trust to A.S. and from the BBSRC (B17958) to Derek Woolfson. S.A.M. was supported by a studentship from the government of the United Arab Emirates.
REFERENCES
Adamson, A. L., and S. Kenney. 1999. The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J. Virol. 73:6551-6558.
Agre, P., P. F. Johnson, and S. L. McKnight. 1989. Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science 246:922-926.
Alber, T. 1992. Structure of the leucine zipper. Curr. Opin. Genet. Dev. 2:205-210.
AuCoin, D. P., K. S. Colletti, S. A. Cei, I. Papouskova, M. Tarrant, and G. S. Pari. 2004. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP). Virology 318:542-555.
AuCoin, D. P., K. S. Colletti, Y. Xu, S. A. Cei, and G. S. Pari. 2002. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication. J. Virol. 76:7890-7896.
Boshoff, C. 1998. Kaposi's sarcoma-associated herpesvirus: the second human gammaherpesvirus. Epstein-Barr Virus Rep. 5:3-9.
Boshoff, C., and R. A. Weiss. 1998. Kaposi's sarcoma associated herpesvirus. Adv. Cancer Res. 75:57-86.
Busch, S. J., and P. Sassone-Corsi. 1990. Dimers, leucine zippers and DNA-binding domains. Trends Genet. 6:36-40.
Cox, A., M. M. Arroyo, and K. H. Mayo. 2001. Folding of ?pep-4 ?-sheet sandwich dimers and tetramers is influenced by aliphatic hydrophobic residues at the intersubunit interface. Biochem. J. 357:739-747.
Dong, A., P. Huang, and W. S. Caughey. 1990. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 29:3303-3308.
Dourmishev, L. A., A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac. 2003. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol. Mol. Biol. Rev. 67:175-212.
Feederle, R., M. Kost, M. Baumann, A. Janz, E. Drouet, W. Hammerschmidt, and H. J. Delecluse. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19:3080-3089.
Flemington, E. K. 2001. Herpesvirus lytic replication and the cell cycle: arresting new developments. J. Virol. 75:4475-4481.
Gruffat, H., S. Portes-Sentis, A. Sergeant, and E. Manet. 1999. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1. J. Gen. Virol. 80:557-561.
Hicks, M. R., S. S. Al-Mehairi, and A. J. Sinclair. 2003. The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding. J. Virol. 77:8173-8177.
Hicks, M. R., S. Balesaria, C. Medina-Palazon, M. J. Pandya, D. N. Woolfson, and A. J. Sinclair. 2001. Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. J. Virol. 75:5381-5384.
Higgins, D. G. 1994. CLUSTAL V: multiple alignment of DNA and protein sequences. Methods Mol. Biol. 25:307-318.
Hirst, J. D., M. Vieth, J. Skolnick, and C. L. Brooks III. 1996. Predicting leucine zipper structures from sequence. Protein Eng. 9:657-662.
Hwang, S., Y. Gwack, H. Byun, C. Lim, and J. Choe. 2001. The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREB-binding protein (CBP) and represses CBP-mediated transcription. J. Virol. 75:9509-9516.
Jenner, R. G., and C. Boshoff. 2002. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim. Biophys. Acta 1602:1-22.
Kelly, S. M., and N. C. Price. 1997. The application of circular dichroism to studies of protein folding and unfolding. Biochim. Biophys. Acta 1338:161-185.
Kelly, S. M., and N. C. Price. 2000. The use of circular dichroism in the investigation of protein structure and function. Curr. Protein Pept. Sci. 1:349-384.
Kouzarides, T., G. Packham, A. Cook, and P. J. Farrell. 1991. The BZLF1 protein of EBV has a coiled coil dimerization domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene 6:195-204.
Kouzarides, T., and E. Ziff. 1989. Behind the Fos and Jun leucine zipper. Cancer Cells 1:71-76.
Lin, C. L., H. Li, Y. Wang, F. X. Zhu, S. Kudchodkar, and Y. Yuan. 2003. Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin. J. Virol. 77:5578-5588.
Lin, S. F., D. R. Robinson, G. Miller, and H. J. Kung. 1999. Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus. J. Virol. 73:1909-1917.
Lupas, A., M. Van Dyke, and J. Stock. 1991. Predicting coiled coils from protein sequences. Science 252:1162-1164.
Mauser, A., S. Saito, E. Appella, C. W. Anderson, W. T. Seaman, and S. Kenney. 2002. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 76:12503-12512.
Miller, G. 1989. The switch between EBV latency and replication. Yale J. Biol. Med. 62:205-213.
Moore, P., and Y. Chang. 1998. Identification of Kaposi's sarcoma-associated sequences of non-human origin. Epstein-Barr Virus Rep. 5:1-2.
Park, J., T. Seo, S. M. Hwang, D. Lee, Y. Gwack, and J. Choe. 2000. The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity. J. Virol. 74:11977-11982.
Portes-Sentis, S., E. Manet, G. Gourru, A. Sergeant, and H. Gruffat. 2001. Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein. J. Gen. Virol. 82:507-512.
Richardson, J. S., and D. C. Richardson. 2002. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl. Acad. Sci. USA 99:2754-2759.
Russo, J. J., R. A. Bohenzky, M.-C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93:14862-14867.
Schepers, A., D. Pich, and W. Hammerschmidt. 1996. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1. Virology 220:367-376.
Schepers, A., D. Pich, and W. Hammerschmidt. 1993. A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. EMBO J. 12:3921-3929.
Schultz, T. F. 1998. Kaposi's sarcoma-associated herpesvirus (HHV-8). J. Gen. Virol. 79:1573-1591.
Schultz, T. F. 1998. KSHV—the middle game. Epstein-Barr Virus Rep. 5:101-107.
Schwarzmann, F., M. Jager, N. Prang, and H. Wolf. 1998. The control of lytic replication of Epstein-Barr virus in B lymphocytes. Int. J. Mol. Med. 1:137-142.
Seaman, W. T., D. S. Ye, R. X. Wang, E. E. Hale, M. Weisse, and E. B. Quinlivan. 1999. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263:436-449.
Sinclair, A. J. 2003. bZIP proteins of human gamma herpesviruses. J. Gen. Virol. 84:1941-1949.
Sinclair, A. J., and P. J. Farrell. 1992. Epstein-Barr virus transcription factors. Cell Growth Differ. 3:557-563.
Speck, S. H., T. Chatila, and E. Flemington. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5:399-405.
Struhl, K. 1989. Helix-turn-helix, zinc-finger, and leucine-zipper motifs for eukaryotic transcriptional regulatory proteins. Trends Biochem. Sci. 14:137-140.
Talbot, S. J., and D. H. Crawford. 2004. Viruses and tumours—an update. Eur. J. Cancer 40:1998-2005.
Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
Wang, S. E., F. Y. Wu, H. Chen, M. Shamay, Q. Zheng, and G. S. Hayward. 2004. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 78:4248-4267.
Wang, Y., H. Li, M. Y. Chan, F. X. Zhu, D. M. Lukac, and Y. Yuan. 2004. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J. Virol. 78:8615-8629.
West, M. J., H. M. Webb, A. J. Sinclair, and D. N. Woolfson. 2004. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C. J. Virol. 78:9431-9445.
Wu, F. Y., H. Chen, S. E. Wang, C. M. apRhys, G. Liao, M. Fujimuro, C. J. Farrell, J. Huang, S. D. Hayward, and G. S. Hayward. 2003. CCAAT/enhancer-binding protein interacts with ZTA and mediates ZTA-induced p21CIP-1 accumulation and G1 cell cycle arrest during the Epstein-Barr virus lytic cycle. J. Virol. 77:1481-1500.
Wu, F. Y., Q. Q. Tang, H. Chen, C. ApRhys, C. Farrell, J. Chen, M. Fujimuro, M. D. Lane, and G. S. Hayward. 2002. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-. Proc. Natl. Acad. Sci. USA 99:10683-10688.
Zerby, D., C. J. Chen, E. Poon, D. Lee, R. Shiekhattar, and P. M. Lieberman. 1999. The amino-terminal C/H1 domain of CREB-binding protein mediates Zta transcriptional activation of latent Epstein-Barr virus. Mol. Cell. Biol. 19:1617-1626.
Zhang, Q., D. Gutsch, and S. Kenney. 1994. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14:1929-1938.
Zhu, F. X., T. Cusano, and Y. Yuan. 1999. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J. Virol. 73:5556-5567.(Salama Al Mehairi, Eleano)